scholarly journals Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
O’Sam Shibeeb ◽  
Anagha Vaze ◽  
Mark Gillies ◽  
Timothy Gray
Keyword(s):  
Macular Oedema ◽  
Laser Photocoagulation ◽  
Intravitreal Bevacizumab ◽  
Argon Laser ◽  
Macular Telangiectasia ◽  
Argon Laser Photocoagulation ◽  
Intravitreal Aflibercept ◽  
Idiopathic Macular Telangiectasia ◽  
The Right

We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitreal bevacizumab and argon laser photocoagulation. The patient was then treated with intravitreal aflibercept injections, following which the macular oedema was completely resolved and his vision was significantly improved. Intravitreal aflibercept injection appears to improve vision and reduce persistent macular oedema secondary to type 1 IMT and demonstrated promising anatomical and visual outcomes.

scholarly journals Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)

2014 ◽  
Vol 2014 ◽  
pp. 1-5
Author(s):  
Mohamed Loutfi ◽  
Thomas Papathomas ◽  
Ahmed Kamal
Keyword(s):  
Visual Acuity ◽  
Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Visual Disturbance ◽  
Cystoid Macular Oedema ◽  
Dexamethasone Intravitreal Implant ◽  
Macular Telangiectasia ◽  
Intravitreal Implant ◽  
The Right

A 65-year-old female presented with visual disturbance in her right eye lasting for over 2 months. Following investigations, she was diagnosed with MacTel type 1 in the right eye. Visual symptoms were refractory to initial treatment with intravitreal bevacizumab and thereafter intravtireal triamicinolone. The patient was then treated with Ozurdex, following which central macular thickness (CMT) decreased (from 397 μm to 286 μm) and visual acuity deteriorated (from logMAR 0.48 to 0.59). At 14 weeks posttreatment with Ozurdex, a recurrence of cystoid macular oedema (CMO) was observed. Following a second Ozurdex, visual acuity improved (from logMAR 0.7 to 0.64) and CMT decreased (from 349 μm to 279 μm). An additional recurrence of CMO was observed at eighteen weeks following the second Ozurdex. Following a third Ozurdex injection visual acuity deteriorated (from logMAR 0.74 to 0.78) and CMT decreased (from 332 μm to 279 μm).Conclusion. Treatment of macular oedema secondary to MacTel with Ozurdex demonstrated promising anatomical outcomes. However, visual outcomes continued to gradually deteriorate.

scholarly journals Argon laser photocoagulation for diabetic macular oedema

Eye ◽  
2006 ◽  
Vol 20 (12) ◽  
pp. 1471-1472
Author(s):  
N E Sinclair ◽  
A Booth ◽  
A Clover ◽  
R Newsom
Keyword(s):  
Macular Oedema ◽  
Laser Photocoagulation ◽  
Diabetic Macular Oedema ◽  
Argon Laser ◽  
Argon Laser Photocoagulation

Active iris vascular tufts bleeding successfully treated with argon laser photocoagulation

2018 ◽  
Vol 28 (2) ◽  
pp. 241-242 ◽  
Author(s):  
Ambreen Sarmad ◽  
Fadi Alfaqawi ◽  
Monali Chakrabarti ◽  
Arijit Mitra ◽  
Bushra Mushtaq
Keyword(s):  
Visual Acuity ◽  
Intraocular Pressure ◽  
Case Report ◽  
Laser Photocoagulation ◽  
Argon Laser ◽  
Active Bleeding ◽  
Blurred Vision ◽  
Argon Laser Photocoagulation ◽  
The Right ◽  
Effective Use

Purpose: Iris vascular tufts (IVT) are rare biomicroscopic capillary outgrowths from the pupillary margins. Patients are usually asymptomatic until presenting with blurred vision due to spontaneous hyphema or with raised intraocular pressure. Case report: A 61-year-old woman presented to eye casualty with left eye (LE) blurred vision and discomfort for 1 day. Her external ocular examination was unremarkable and visual acuity was 6/6 in the right eye (RE) and 6/9 in the LE. Biomicroscopic examination revealed a 2-mm hyphema in her LE and bilateral multiple small IVT and active bleeding from IVT at the pupillary margin of the LE at the 5 o’clock position. Diagnosis of LE active bleeding from IVT was made and she underwent argon laser photocoagulation directed at the source of bleeding. The bleeding stopped immediately after the second burn. She was followed up for 3 months; her visual acuity was 6/5 and 6/6 in the RE and LE, respectively, with no further problems. Conclusions: Iris vascular tufts are benign and recurrent hemorrhages are unlikely. Therefore, definitive argon laser photocoagulation or surgical treatment are reserved to arrest further episodes of hyphema. Our case demonstrates the effective use of argon laser photocoagulation to completely arrest active bleeding from IVT and excellent recovery of hyphema with no further problems for 5 years.

scholarly journals Efficacy of Laser Photocoagulation for Type 1 Idiopathic Macular Telangiectasia: A Retrospective Study

2021 ◽  
pp. 9-16
Author(s):  
Hirofumi Kono ◽  
Katsuhiko Yokoyama ◽  
Daiji Kishi ◽  
Kenichi Kimoto ◽  
Toshiaki Kubota
Keyword(s):  
Visual Acuity ◽  
Macular Edema ◽  
Laser Photocoagulation ◽  
Macular Thickness ◽  
University Hospital ◽  
Type I ◽  
Central Macular Thickness ◽  
Macular Telangiectasia ◽  
Idiopathic Macular Telangiectasia

Aims: The aim of this study was to evaluate the efficacy of laser photocoagulation for type 1 idiopathic macular telangiectasia (MacTel). Study Design: Retrospective case series Place and Duration of Study: Department of Ophthalmology, Oita University Hospital during the period from 2004 to 2013. Patients and Methods: Six eyes of 6 patients with type 1 MacTel diagnosed consecutively in the Oita University Hospital during the period from 2004 to 2013 were studied. They showed macular edema and their visual acuity were deteriorated due to leakage from the aneurysms. Four patients were male and two were female with an average age of 64 years (range: 41 to 74 years). Informed consent was obtained from each patient and the laser photocoagulation was applied to leaky aneurysms in all eyes. The central macular thickness (CMT) was measured by optical coherence tomography (OCT). Mean follow up period was 44 months (range: 24 - 63 months).  Results: Mean visual acuity significantly increased from logMAR 0.25±0.27 at baseline to logMAR 0.11±0.14 (P<0.05) at the last visit. Visual acuity improved more than 0.2 logMAR in five eyes and was stable (gain or loss of < 0.3 logMAR) in one eye. Mean central macular thickness significantly decreased from 454±181 μm at baseline to 231±67 μm (P<0.05) at the last visit. Macular edema was not detected by OCT inany patients at the last visit. Conclusion: In type I MacTel, laser photocoagulation may achieve a visual improvement and normalize the central macular thickness.

scholarly journals Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia

Eye ◽  
2010 ◽  
Vol 24 (9) ◽  
pp. 1492-1497 ◽  
Author(s):  
K Takayama ◽  
S Ooto ◽  
H Tamura ◽  
K Yamashiro ◽  
A Otani ◽  
...  
Keyword(s):  
Intravitreal Bevacizumab ◽  
Macular Telangiectasia ◽  
Idiopathic Macular Telangiectasia

Argon Laser Photocoagulation for the Treatment of Diabetic Macular Oedema

1992 ◽  
Vol 205 (1) ◽  
pp. 15-18 ◽  
Author(s):  
Milan Ivanišević ◽  
Miladin Štriga ◽  
Rikard Stanić
Keyword(s):  
Macular Oedema ◽  
Laser Photocoagulation ◽  
Diabetic Macular Oedema ◽  
Argon Laser ◽  
Argon Laser Photocoagulation
Sign in / Sign up

Export Citation Format

Share Document